New JIAS supplement on vaccines for the elimination of STIs

The Journal of the International AIDS Society (JIAS) released a new supplement, titled “Towards Elimination of Sexually Transmitted Infections: Research Developments and Vaccine Uptake”. The supplement was guest edited by Jeanne Marrazzo (Infectious Diseases Society of America, USA), Nelly R Mugo (University of Washington, USA, & Kenya Medical Research Institute, Kenya) and Yves Levy (Vaccine Research Institute/Inserm Université Paris Est Créteil, France).

Despite remarkable advances in vaccine science, sexually transmitted infections (STIs) remain a persistent and growing global health challenge. Rates of STIs continue to rise in many parts of the world. Meanwhile, stigma, under-investment and inequitable access to prevention and care continue to hinder efforts to reduce their long-term health consequences.

The supplement examines the scientific, social and implementation challenges shaping the STIs prevention landscape, including the influence of stigma on vaccine acceptance, advances in STIs vaccine research and development, and strategies to improve access to and uptake of both existing STIs vaccines and those currently in development.

At a time when advances in mRNA technology, artificial intelligence, structural biology, novel adjuvants and vaccine delivery systems are transforming the biomedical field, the articles in this collection consider how the same scientific momentum can be applied to STIs prevention. As Guest Editors Jeanne Marrazzo, Nelly R Mugo and Yves Levy emphasize, achieving this will require more sustained investment and global commitment.

Access the supplement here.

The Journal of the International AIDS Society is an open-access, peer-reviewed journal, which publishes HIV-related research from various disciplines and particularly encourages submissions in implementation sciences.